ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

NCAB Approves CCP, Agrees To Compromise On Including Control

May 21, 1982

Norton Succeeds Einhorn As ASCO President, Colorado’s Paul Bunn Is President-Elect.

May 11, 2001

NCI’s Schneiderman Reports Result Of Better Treatment, Some Drop In Incidence, Overall Increase As Kennedy Hearings Open

March 9, 1979

In Brief: NCAB To Hear NCI Staff Plans For Implementing Recommendation On Nutrition & Cancer Task Force

October 1, 1982

FCRC Preproposal Conference Draws 36 Institutions

August 14, 1981

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

October 28, 2011